Scientific and clinical support for the use of dehydrated amniotic membrane in wound management

Wounds

Volumn 24, Issue 10, 2012, Pages 299-307

  Fetterolf, Donald E ^a   Snyder, Robert J ^b  

^a MiMedx Group Inc   (United States)

^b BARRY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867789889     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. John, T. Human amniotic membrane transplantation: past, present, and future. Ophthalmol Clin North Am. 2003;16(1):43-65.
2. Davis JW. Skin transplantation with a review of 550 cases at the Johns Hopkins Hospital. Johns Hopkins Med J. 1910;15:307-396.
3. Sabella N. Use of fetal membranes in skin grafting. Med Records NY. 1913;83:478-480.
4. Stern M. The grafting of preserved amniotic membrane to burned and ulcerated surfaces, substituting skin grafts. JAMA. 1913;60(13):973-974.
5. De Roth A. Plastic repair of conjunctival defects with fetal membranes. Arch Ophthalmol. 1940;23(3):522-525.
6. Internal records, Surgical Biologics, Inc, Kennesaw, GA. Accessed August 23, 2012.
7. Cornwell KG, Landsman A, James KS. Extracellular matrix biomaterials for soft tissue repair. Clin Podiatr Med Surg. 2009;26(4):507-523.
8. Bose B. Burn wound dressing with human amniotic membrane. Ann R Coll Surg Engl. 1979;61(6):444-447.
9. Quinby WC, Hoover HC, Scheflan M, et al. Clinical trials of amniotic membranes in burn wound care. Plast Reconstr Surg. 1982;70:711-716.
10. Sawhney CP. Amniotic membrane as a biological dressing in the management of burns. Burns. 1989;15(5):339-342.
11. Pigeon J. Treatment of second-degree burns with amniotic membranes. Can Med Assoc J. 1960;83:844-845.
12. Ganatra MA. Amniotic Membrane in Surgery. J Pak Med Assoc. 2003;53(1):29-32.
13. Koziak A, Salagierski M, Marcheluk A, Szczesniewski R, Sosnowski M. Early experience in reconstruction of long ureteral strictures with allogenic amniotic membrane. Int J Urol. 2007;14(7):607-610.
14. Tao H, Fan H. Implantation of amniotic membrane to reduce postlaminectomy epidural adhesions. Eur Spine J. 2009;18(8):1202-1212.
15. Chou CT, Lee C, Hwang JL. Amniotic membrane used for vulvar adhesion treatment. Arch Gynecol Obstet. 2001;265(4):223-224.
16. Fotopoulou C, Sehouli J, Gehrmann N, Schoenborn I, Lichtenegger. Functional and anatomic results of amnion vaginoplasty in young women with Mayer-Rokitansky-Küster-Hauser syndrome. Fertil Steril. 2010;94(1):317-323.
17. Demirkan F, Colakoglu N, Herek O, Erkula G. The use of amniotic membrane in flexor tendon repair: ancexperimental model. Arch Orthop Trauma Surg. 2002;122(7):396-399.
18. Premier Laboratories, LLC. Longmont, CO. Immunohistochemical staining to dtermine the presence or absence of collagen IV, V, and VII, Laminin, TGF-beta, EGF, FGF, PDGF-alpha, and PDGF-beta in non-processed human amniotic membrane as opposed to processed amniotic membrane samples. Study Numbers: 2011-261, 2011-432. Study completed 2011.
19. Schmidt W. The amniotic fluid compartment: the fetal habitat. Adv Anat Embryol Cell Biol. 1992;127:1-100.
20. Schultz GS, Davidson JM, Kirsner RS, Bornstein P, Herman IM. Dynamic reciprocity in the wound microenvironment. Wound Repair Regen. 2011;19(2):134-148.
21. Akle C, Adinolfi M, Welsh KI, Leibowitz S, McColl I. Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet. 1981;2(8254):1003-1005.
22. Park CY, Kohanim S, Zhu L, Gehlbach PL, Chuck RS. Immunosuppressive property of dried human amniotic membrane. Ophthalmic Res. 2008;41(2):112-3.
23. Fortunato SJ, Menon R, Lombardi SJ. Presence of four tissue inhibitors of matrix metalloproteinases (TIMP-1,-2,-3 and-4) in human fetal membranes. Am J Reprod Immunol. 1998;40(6):395-400.
24. Paradowska E, Blach-Olszewska Z, Gejdel E. Constitutive and induced cytokine production by human placenta and amniotic membrane at term. Placenta. 1997;18(5-6);441-446.
25. Kim JS, Kim JC, Na BK, Jeong JM, Song CY. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Exp Eye Res. 2000;70(3):329-337.
26. Hao Y, Ma DH, Hwang DG, Kim WS, Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea. 2000;19(3):348-352.
27. Tseng SC, Li DQ, Ma X. Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol. 1999;179(3):325-335.
28. King AE, Paltoo A, Kelly RW, et al. Expression of natural antimicrobials by human placenta and fetal membranes. Placenta. 2007;28(2-3):161-169.
29. Talmi, Y, Sigler, L, Inge, E, Finkelstein Y, Zohar Y. Antibacterial Properties of Human Amniotic Membranes. Placenta. 1991;12(3):285-288.
30. Mermet I, Pottier N, Sainthillier JM, et al. Use of amniotic membrane transplantation in the treatment of venous leg ulcers. Wound Repair Regen. 2007;15(4):459-464.
31. Adly OA, Moghazy AM, Abbas AH, et al. Assessment of amniotic and polyurethane membrane dressings in the treatment of burns. Burns. 2010;36(5):703-710.
32. Lorusso R, Geraci, L, Masellis, M. The treatment of superficial burns with biological and synthetic material: frozen amnion and biobrane. Annals of the MBC. 1989;2(2):79-84.
33. Niknejad H, Peirovi H, Jorjani M, et al. Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater. 2008;15:88-99.
34. Chen E, Tofe A. A literature review of the safety and biocompatibility of amnion tissue. J Impl Adv Clin Dent. 2010;2(3):67-75.
35. Toda A, Okabe M, Yoshida T, Nikaido T. The potential of amniotic membrane/amnion-derived cells for regeneration of various tissues. J Pharmacol Sci. 2007;105(3):215-228.
36. Grey JE, Harding KG, Enoch S. Venous and arterial leg ulcers. BMJ. 2006;332(7537):347-350.
37. Bergan JJ, Schmid-Schönbein GW, Coleridge Smith PD, et al. Mechanisms of disease: chronic venous disease. N Engl J Med. 2006;(355):488-498.
38. Pesteil F, Drouet M, Rousanne M, Lacroix P. Amniotic membrane: An innovative treatment of refractory vascular ulcers. Phlebolymphology. 2009;16(2):259-265.
39. Lineen E, Namias N. Biologic dressing in burns. J Craniofac Surg. 2008;19(4):923-928.
40. Sharma SC, Bagree MM, Bhat AL, Banga BB, Singh MP. Amniotic membrane is an effective burn dressing material. Jpn J Surg. 1985;15(2):140-143.
41. Kesting MR, Wolff KD, Hohlweg-Majert B, Steinstraesser L. The role of allogenic amniotic membrane in burn treatment. J Burn Care Res. 2008;29(6):907-916.
42. Singh R, Purohit S, Chacharkar MP, Bhandari PS, Bath AS. Microbiological safety and clinical efficacy of radiation sterilized amniotic membranes for treatment of second-degree burns. Burns. 2007;33(4):505-510.
43. Branski LK, Herndon DN, Celis MM, et al. Amnion in the treatment of pediatric partial-thickness facial burns. Burns. 2008;34(3):393-399.
44. Ganatra MA, Durrani KM. Method of obtaining and preparation of fresh human amniotic membrane for clinical use. J Pak Med Assoc.1996;46(6):126-128.
45. Warriner RA, Snyder RJ, Cardinal MH. Differentiating diabetic foot ulcers that are unlikely to heal by 12 weeks following achieving 50% percent area reduction at 4 weeks. Int Wound J. 2011;8(6):632-637.
46. Margolis D, Kantor J, Berlin J. Healing of neuropathic ulcers receiving standard treatment: a meta-analysis. Diabetes Care. 1999;22(5):692-695.
47. Sheehan P, Jones P, Caselli A, Giurini JM, Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12 week prospective trial. Diabetes Care. 2003;26(6):1879-1882.
48. Snyder R, Cardinal M, Dauphinee DM, Stavosky J. A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeks. Ostomy Wound Manage. 2010;56(3):44-50.
49. Snyder R, Cardinal M, Dauphinee D, Stavosky J. Diabetic foot ulcers: less than 50% closure in 4 weeks predicts failure to heal by 12 weeks. Poster presented at Diabetic Limb Salvage Conference, September 24-26, 2009; Washington, DC.
50. Snyder RJ, Richter D, Hill ME. A retrospective study of sequential therapy with advanced wound care products versus saline gauze dressings: comparing healing and cost. Ostomy Wound Manage. 2010;56(11A):9-15.
51. Lazaro-Martinez JL, Aragn-Sanchez FJ, Garcia-Morales E, et al. A retrospective analysis of the cost-effectiveness of collagen/oxidized regenerated cellulose dressing in the treatment of neuropathic diabetic foot ulcers. Ostomy Wound Manage. 2010;56(11A):4-8.
52. Steed DL, Attinger C, Colaizzi T, et al. Guidelines for the treatment of diabetic ulcers. Wound Repair Regen. 2006;14(6):680-692.
53. Eckman MH, Greenfield S, Mackey WC, et al. Foot infections in diabetic patients: decision and cost effectiveness analysis. JAMA. 1995;273(9):712-720.
54. Ovington LG. Hanging wet to dry dressing out to dry. Home Healthc Nurse. 2001;19(8):477-483.
55. Diño BR, Eufemio G, De Villa M, Reysio-Cruz M, Jurado RA. The use of fetal membrane homografts in the local management of burns. J. Philippine Med Assoc. 1965;41(12) (suppl):890-898.
56. Hermans MH. Preservation methods of allografts and their (lack of) influence on clinical results in partial thickness burns. Burns. 2011;37(5):873-881.
57. Riau AK, Beuerman RW, Lim LS, Mehta JS. Preservation, sterilization and de-epithelialization of human amniotic membrane for use in ocular surface reconstruction. Biomaterials. 2010; 31(2):216-225.
58. Singh R, Gupta P, Kumar P, Kumar A, Chacharkar MP. Properties of air dried radiation processed amniotic membranes under different storage conditions. Cell Tissue Bank. 2003; 4 (2-4):95-100.
59. von Versen-Höynck F, Syring C, Bachman S, Möller DE. The influence of different preservation and sterilisation steps on the histological properties of amnion allografts-light and scanning electron microscopic studies. Cell Tissue Bank. 2004;5(1):45-56.
60. Marston WA, Hanft J, Norwood P, Pollack R; and Dermagraft Diabetic Foot Ulcer Study Group. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care. 2003;26(6);1701-1705.
61. Hao Y, Ma DH, Hwang DG, Kim WS, Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea. 2000; (19)3;348-352.
62. Keelan JA, Blumenstein M, Helliwell RJ, Sato TA, Marvin KW, Mitchell MD. Cytokines, prostaglandins and parturition-a review. Placenta. 2003; 24 Supplement A: S33-S46.